NCT02813135 2026-01-16
ESMART
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT00382733 2013-07-22
Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
Accelerated Community Oncology Research Network
Phase 1/2 Completed
NCT00611468 2011-08-22
Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors
Accelerated Community Oncology Research Network
Phase 1 Completed
NCT00193583 2011-05-04
Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors
SCRI Development Innovations, LLC
Phase 1 Completed
NCT00412503 2009-08-07
Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Completed
NCT00193570 2009-01-23
Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors
SCRI Development Innovations, LLC
Phase 1 Completed